Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US Meeting Set For CBDs’ Impact On Pregnancies, Gender-Specific Biological, Psychosocial Effects

Sep 23 2020

• By Eileen Francis

pregnancy, medicine, pharmaceutics, health care and people concept - close up of pregnant woman with prescription and medication jar reading label at pharmacy

Related Content

Unpublished And Under Review? US FDA’s CBD Policy Draft Guidance Still Has Industry Talking

Aug 04 2020

As A Botanical, Cannabidiol Was Next Ingredient Up For AHPA's Guidance On Use In Supplements

Mar 17 2020

Waiting For Cannabidiol Guidance? US FDA Reminds Industry Of ‘Many Other Requirements’

Sep 23 2020

FDA Decision On CBD Use Could Run Up Against Chicken Or Egg Question

Jun 06 2019

FDA To Consider Regulatory Shift Making Cannabis Ingredients Officially Eligible For Use In Dietary Supplements

Dec 28 2018

Additional Topics

International United States Cannabidiol CBD FDA Dietary Supplements Advertising, Marketing & Sales Business Strategies Commercial Compliance Drug Approval Standards Ingredients Manufacturing Policy Regulation Enforcement Safety Consumer Gynecology & Urology

More from Cannabis/CBD

More from Ingredients & Safety

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window